Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination.
Alexander
A
Kreuter
Tim
T
Waterboer
Ulrike
U
Wieland
D000015:Abnormalities, Multiple; D000328:Adult; D001003:Anal Canal / Q000002:abnormalities; D005260:Female; D005836:Genitalia, Female / Q000002:abnormalities; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D008209:Lymphedema / Q000150:complications; D030361:Papillomavirus Infections / Q000150:complications; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D012074:Remission Induction; D013577:Syndrome; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014860:Warts / Q000188:drug therapy* / Q000209:etiology
D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic